Views & Analysis A collaborative approach to greater diversity in clinical tr... The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.
News FDA panel backs Sage’s novel antidepressant but turns down A... Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee at its meeting last week, but the same panel had bad
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face